King Pharmaceuticals KG Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's increase (decrease) in other operating assets?
- King Pharmaceuticals (KG) reported increase (decrease) in other operating assets of -$139K in Q1 2026.
- How has King Pharmaceuticals's increase (decrease) in other operating assets changed year-over-year?
- King Pharmaceuticals's increase (decrease) in other operating assets decreased by 151.5% year-over-year, from $270K to -$139K.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.